Search List of Extended Use Dates to Assist with Drug Shortages
Based on stability data provided by the manufacturers and reviewed by FDA, the following extended use dates are supported for specific lot numbers indicated in the searchable table below. Providers and patients that have the lot numbers in stock will be able to use them through the corresponding new use dates to help with supply. As data become available, this list can continue to expand.
FDA is not requiring or recommending that the identified lot numbers in the following table be relabeled with their new use dates. However, if replacement product becomes available during the extension period, then the agency expects the lots in these tables will be replaced and properly disposed of as soon as possible.
Please contact CDER Drug Shortage Staff at drugshortages@fda.hhs.gov with questions regarding this table.
| Product | Company | NDC Number | Lot Number | Expiration Date (Labeled) | Extended Use Date |
|---|---|---|---|---|---|
| Product | Company | NDC Number | Lot Number | Expiration Date (Labeled) | Extended Use Date |
| Heparin Sodium Injection, 25,000 units/250 mL (100 units/mL) in 5% Dextrose, single dose bag, case of 24 | Hospira, a Pfizer company | 0409-7793-62 | 33403KL00 | 1-Sep-2023 | 1-Apr-2024 |
| Heparin Sodium Injection, 25,000 units/250 mL (100 units/mL) in 5% Dextrose, single dose bag, case of 24 | Hospira, a Pfizer company | 0409-7793-62 | 31201KL00 | 1-Jul-2023 | 1-Feb-2024 |
| Heparin Sodium Injection, 25,000 units/250 mL (100 units/mL) in 5% Dextrose, single dose bag, case of 24 | Hospira, a Pfizer company | 0409-7793-62 | 24401KL00 | 1-Dec-2022 | 1-Jul-2023 |
| Heparin Sodium Injection, 25,000 units/250 mL (100 units/mL) in 5% Dextrose, single dose bag, case of 24 | Hospira, a Pfizer company | 0409-7793-62 | 24402KL00 | 1-Dec-2022 | 1-Jul-2023 |
| Diltiazem Hydrochloride for Injection, 100 mg, single dose vial, tray of 10 | Hospira, a Pfizer company | 0409-4350-03 | 19060DD | 1-Jul-2022 | 1-Jul-2023 |
| Diltiazem Hydrochloride for Injection, 100 mg, single dose vial, tray of 10 | Hospira, a Pfizer company | 0409-4350-03 | 19095DD | 1-Jul-2022 | 1-Jul-2023 |
| Diltiazem Hydrochloride for Injection, 100 mg, single dose vial, tray of 10 | Hospira, a Pfizer company | 0409-4350-03 | 19135DD | 1-Jul-2022 | 1-Jul-2023 |
| Heparin Sodium 25,000 units/250 mL (100 units/mL) in 5% Dextrose Injection, single dose bag, case of 24 | Hospira, a Pfizer company | 0409-7793-62 | 32303KL00 | 1-Aug-2023 | 1-Mar-2024 |
| Etomidate injection, 20 mg/10 mL (2 mg/mL), single dose vial, carton of 10 | Caplin Steriles (Fresenius Kabi label) | 65219-445-10 | G0030921 | 28-Feb-2023 | 31-Aug-2023 |
| Etomidate injection, 20 mg/10 mL (2 mg/mL), single dose vial, carton of 10 | Caplin Steriles (Fresenius Kabi label) | 65219-445-10 | G0040921 | 28-Feb-2023 | 31-Aug-2023 |
| Etomidate injection, 20 mg/10 mL (2 mg/mL), single dose vial, carton of 10 | Caplin Steriles (Fresenius Kabi label) | 65219-445-10 | G0050921 | 28-Feb-2023 | 31-Aug-2023 |
| Etomidate injection, 20 mg/10 mL (2 mg/mL), single dose vial, individual | Caplin Steriles (Fresenius Kabi label) | 65219-445-01 | G0030921 | 28-Feb-2023 | 31-Aug-2023 |
| Etomidate injection, 20 mg/10 mL (2 mg/mL), single dose vial, individual | Caplin Steriles (Fresenius Kabi label) | 65219-445-01 | G0040921 | 28-Feb-2023 | 31-Aug-2023 |
| Etomidate injection, 20 mg/10 mL (2 mg/mL), single dose vial, individual | Caplin Steriles (Fresenius Kabi label) | 65219-445-01 | G0050921 | 28-Feb-2023 | 31-Aug-2023 |
| Etomidate injection, 40 mg/20 mL (2 mg/mL), single dose vial, carton of 10 | Caplin Steriles (Fresenius Kabi label) | 65219-447-20 | G0090921 | 28-Feb-2023 | 31-Aug-2023 |
| Etomidate injection, 40 mg/20 mL (2 mg/mL), single dose vial, carton of 10 | Caplin Steriles (Fresenius Kabi label) | 65219-447-20 | G0100921 | 28-Feb-2023 | 31-Aug-2023 |
| Etomidate injection, 40 mg/20 mL (2 mg/mL), single dose vial, individual | Caplin Steriles (Fresenius Kabi label) | 65219-447-02 | G0090921 | 28-Feb-2023 | 31-Aug-2023 |
| Etomidate injection, 40 mg/20 mL (2 mg/mL), single dose vial, individual | Caplin Steriles (Fresenius Kabi label) | 65219-447-02 | G0100921 | 28-Feb-2023 | 31-Aug-2023 |
| Etomidate injection, 40 mg/20 mL (2 mg/mL), single dose vial, carton of 10 | Caplin Steriles (Fresenius Kabi label) | 65219-447-20 | G0060821 | 31-Jan-2023 | 31-Jul-2023 |
| Etomidate injection, 40 mg/20 mL (2 mg/mL), single dose vial, carton of 10 | Caplin Steriles (Fresenius Kabi label) | 65219-447-20 | G0080821 | 31-Jan-2023 | 31-Jul-2023 |
| Etomidate injection, 40 mg/20 mL (2 mg/mL), single dose vial, individual | Caplin Steriles (Fresenius Kabi label) | 65219-447-02 | G0060821 | 31-Jan-2023 | 31-Jul-2023 |
| Etomidate injection, 40 mg/20 mL (2 mg/mL), single dose vial, individual | Caplin Steriles (Fresenius Kabi label) | 65219-447-02 | G0080821 | 31-Jan-2023 | 31-Jul-2023 |
| Fludarabine phosphate injection, 50 mg/2 mL (25 mg/mL), single-dose vial, individual | Sagent Pharmaceuticals | 25021-242-02 | 100020734 | Jan-2023 | Jul-2023 |
| Potassium phosphates injection (phosphorus 45 mmol/15 mL (3 mmol/mL) and potassium 71 mEq/15 mL (4.7 mEq/mL)), single dose vial, individual | CMP Development, LLC | 46287-024-15 | CR31 | June-2023 | Dec-2023 |
| Potassium phosphates injection (phosphorus 45 mmol/15 mL (3 mmol/mL) and potassium 71 mEq/15 mL (4.7 mEq/mL)), single dose vial, individual | CMP Development, LLC | 46287-024-15 | CR86 | June-2023 | Dec-2023 |
| Potassium phosphates injection (phosphorus 45 mmol/15 mL (3 mmol/mL) and potassium 71 mEq/15 mL (4.7 mEq/mL)), single dose vial, individual | CMP Development, LLC | 46287-024-15 | CS86 | Oct-2023 | Apr-2024 |
| Potassium phosphates injection (phosphorus 45 mmol/15 mL (3 mmol/mL) and potassium 71 mEq/15 mL (4.7 mEq/mL)), single dose vial, individual | CMP Development, LLC | 46287-024-15 | CS89 | Oct-2023 | Apr-2024 |
| Potassium phosphates injection (phosphorus 45 mmol/15 mL (3 mmol/mL) and potassium 71 mEq/15 mL (4.7 mEq/mL)), single dose vial, individual | CMP Development, LLC | 46287-024-15 | CS96 | Oct-2023 | Apr-2024 |
| Potassium phosphates injection (phosphorus 45 mmol/15 mL (3 mmol/mL) and potassium 71 mEq/15 mL (4.7 mEq/mL)), single dose vial, individual | CMP Development, LLC | 46287-024-15 | CT36 | Nov-2023 | May-2024 |
| Potassium phosphates injection (phosphorus 45 mmol/15 mL (3 mmol/mL) and potassium 71 mEq/15 mL (4.7 mEq/mL)), single dose vial, individual | CMP Development, LLC | 46287-024-15 | CT40 | Nov-2023 | May-2024 |
| Potassium phosphates injection (phosphorus 45 mmol/15 mL (3 mmol/mL) and potassium 71 mEq/15 mL (4.7 mEq/mL)), single dose vial, carton of 10 | CMP Development, LLC | 46287-024-10 | CR31 | June-2023 | Dec-2023 |
| Potassium phosphates injection (phosphorus 45 mmol/15 mL (3 mmol/mL) and potassium 71 mEq/15 mL (4.7 mEq/mL)), single dose vial, carton of 11 | CMP Development, LLC | 46287-024-10 | CR86 | June-2023 | Dec-2023 |
| Potassium phosphates injection (phosphorus 45 mmol/15 mL (3 mmol/mL) and potassium 71 mEq/15 mL (4.7 mEq/mL)), single dose vial, carton of 12 | CMP Development, LLC | 46287-024-10 | CS86 | Oct-2023 | Apr-2024 |
| Potassium phosphates injection (phosphorus 45 mmol/15 mL (3 mmol/mL) and potassium 71 mEq/15 mL (4.7 mEq/mL)), single dose vial, carton of 13 | CMP Development, LLC | 46287-024-10 | CS89 | Oct-2023 | Apr-2024 |
| Potassium phosphates injection (phosphorus 45 mmol/15 mL (3 mmol/mL) and potassium 71 mEq/15 mL (4.7 mEq/mL)), single dose vial, carton of 14 | CMP Development, LLC | 46287-024-10 | CS96 | Oct-2023 | Apr-2024 |
| Potassium phosphates injection (phosphorus 45 mmol/15 mL (3 mmol/mL) and potassium 71 mEq/15 mL (4.7 mEq/mL)), single dose vial, carton of 15 | CMP Development, LLC | 46287-024-10 | CT36 | Nov-2023 | May-2024 |
| Potassium phosphates injection (phosphorus 45 mmol/15 mL (3 mmol/mL) and potassium 71 mEq/15 mL (4.7 mEq/mL)), single dose vial, carton of 16 | CMP Development, LLC | 46287-024-10 | CT40 | Nov-2023 | May-2024 |
| Echothiophate iodide for ophthalmic solution, 6.25 mg/5 mL (0.125%), kit | Fera Pharmaceuticals, LLC | 48102-053-05 | 1850-140A | May-2023 | May-2024 |
| Hydrocortisone sodium succinate injection, 100 mg, single dose vial, pack of 25 | Pfizer | 0009-0011-04 | EG4000 | 31-Jan-2023 | 30-Jun-2023 |
| Hydrocortisone sodium succinate injection, 100 mg, single dose vial, pack of 25 | Pfizer | 0009-0011-04 | DX9532 | 31-Mar-2023 | 31-Aug-2023 |
| Hydrocortisone sodium succinate injection, 100 mg, single dose vial, pack of 25 | Pfizer | 0009-0011-04 | EK5929 | 30-Apr-2023 | 30-Sep-2023 |
| Hydrocortisone sodium succinate injection, 100 mg, single dose vial, pack of 25 | Pfizer | 0009-0011-04 | EA7641 | 30-Apr-2023 | 30-Sep-2023 |
| Hydrocortisone sodium succinate injection, 100 mg, single dose vial, pack of 25 | Pfizer | 0009-0011-04 | EA7642 | 30-Apr-2023 | 30-Sep-2023 |
| Hydrocortisone sodium succinate injection, 100 mg, single dose vial, pack of 25 | Pfizer | 0009-0011-04 | ED7612 | 30-Apr-2023 | 30-Sep-2023 |
| Hydrocortisone sodium succinate injection, 100 mg, single dose vial, pack of 25 | Pfizer | 0009-0011-04 | EC9036 | 30-Apr-2023 | 30-Sep-2023 |
| Hydrocortisone sodium succinate injection, 100 mg, single dose vial, pack of 25 | Pfizer | 0009-0011-04 | EC9035 | 30-Apr-2023 | 30-Sep-2023 |
| Hydrocortisone sodium succinate injection, 100 mg, single dose vial, pack of 25 | Pfizer | 0009-0011-04 | EE6558 | 31-May-2023 | 31-Oct-2023 |
| Hydrocortisone sodium succinate injection, 100 mg, single dose vial, pack of 25 | Pfizer | 0009-0011-04 | EE2603 | 31-May-2023 | 31-Oct-2023 |
| Hydrocortisone sodium succinate injection, 100 mg, single dose vial, pack of 25 | Pfizer | 0009-0011-04 | ED7613 | 31-May-2023 | 31-Oct-2023 |
| Hydrocortisone sodium succinate injection, 100 mg, single dose vial, pack of 25 | Pfizer | 0009-0011-04 | EE2600 | 31-May-2023 | 31-Oct-2023 |
| Hydrocortisone sodium succinate injection, 100 mg, single dose vial, pack of 25 | Pfizer | 0009-0011-04 | EF8716 | 30-Jun-2023 | 30-Nov-2023 |
| Hydrocortisone sodium succinate injection, 100 mg, single dose vial, pack of 25 | Pfizer | 0009-0011-04 | EF4252 | 30-Jun-2023 | 30-Nov-2023 |
| Hydrocortisone sodium succinate injection, 100 mg, single dose vial, pack of 25 | Pfizer | 0009-0011-04 | EK5931 | 30-Jun-2023 | 30-Nov-2023 |
| Hydrocortisone sodium succinate injection, 100 mg, single dose vial, pack of 25 | Pfizer | 0009-0011-04 | EF8717 | 30-Jun-2023 | 30-Nov-2023 |
| Hydrocortisone sodium succinate injection, 100 mg, single dose vial, pack of 25 | Pfizer | 0009-0011-04 | EF0995 | 30-Jun-2023 | 30-Nov-2023 |
| Hydrocortisone sodium succinate injection, 100 mg, single dose vial, pack of 25 | Pfizer | 0009-0011-04 | EF0996 | 30-Jun-2023 | 30-Nov-2023 |
| Hydrocortisone sodium succinate injection, 100 mg, single dose vial, pack of 25 | Pfizer | 0009-0011-04 | EF0994 | 30-Jun-2023 | 30-Nov-2023 |
| Hydrocortisone sodium succinate injection, 100 mg, single dose vial, pack of 25 | Pfizer | 0009-0011-04 | EH3512 | 31-Jul-2023 | 31-Dec-2023 |
| Hydrocortisone sodium succinate injection, 100 mg, single dose vial, pack of 25 | Pfizer | 0009-0011-04 | EG7018 | 31-Jul-2023 | 31-Dec-2023 |
| Hydrocortisone sodium succinate injection, 100 mg, single dose vial, pack of 25 | Pfizer | 0009-0011-04 | EG3999 | 31-Jul-2023 | 31-Dec-2023 |
| Hydrocortisone sodium succinate injection, 100 mg, single dose vial, pack of 25 | Pfizer | 0009-0011-04 | EJ6423 | 31-Jul-2023 | 31-Dec-2023 |
| Hydrocortisone sodium succinate injection, 100 mg, single dose vial, pack of 25 | Pfizer | 0009-0011-04 | EK2710 | 31-Aug-2023 | 31-Jan-2024 |
| Hydrocortisone sodium succinate injection, 100 mg, single dose vial, pack of 25 | Pfizer | 0009-0011-04 | EK0104 | 31-Aug-2023 | 31-Jan-2024 |
| Hydrocortisone sodium succinate injection, 100 mg, single dose vial, pack of 25 | Pfizer | 0009-0011-04 | EK2371 | 31-Aug-2023 | 31-Jan-2024 |
| Hydrocortisone sodium succinate injection, 100 mg, single dose vial, pack of 25 | Pfizer | 0009-0011-04 | EL4877 | 31-Aug-2023 | 31-Jan-2024 |
| Hydrocortisone sodium succinate injection, 100 mg, single dose vial, pack of 25 | Pfizer | 0009-0011-04 | EJ6424 | 31-Aug-2023 | 31-Jan-2024 |
| Hydrocortisone sodium succinate injection, 100 mg, single dose vial, pack of 25 | Pfizer | 0009-0011-04 | EK0105 | 30-Sep-2023 | 29-Feb-2024 |
| Hydrocortisone sodium succinate injection, 100 mg, single dose vial, pack of 25 | Pfizer | 0009-0011-04 | EN8908 | 30-Sep-2023 | 29-Feb-2024 |
| Hydrocortisone sodium succinate injection, 100 mg, single dose vial, pack of 25 | Pfizer | 0009-0011-04 | EN0670 | 30-Sep-2023 | 29-Feb-2024 |
| Hydrocortisone sodium succinate injection, 100 mg, single dose vial, pack of 25 | Pfizer | 0009-0011-04 | EN8907 | 30-Sep-2023 | 29-Feb-2024 |
| Kepivance (palifermin) lyophilized powder for injection, 6.25 mg, single-use vial, pack of 6 | Swedish Orphan Biovitrum AB (Sobi) | 66658-112-06 | 940787 | 30-Apr-2023 | 30-Apr-2024 |
| Kepivance (palifermin) lyophilized powder for injection, 6.25 mg, single-use vial, pack of 3 | Swedish Orphan Biovitrum AB (Sobi) | 66658-112-03 | 940788 | 30-Apr-2023 | 30-Apr-2024 |